Cambrex Corporation (CBM:NYSE) Investor Relations Material

Overview

In an article for the Wall Street Journal, it was noted that Cambrex Corporation is a forward-thinking life sciences company that is focused on developing products, services, and technologies that will speed up the commercialization and development of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates, and enhanced drug delivery products targeting both branded and generic pharmaceuticals. Cambrex Corporation has an extensive range of manufacturing capabilities, which includes enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances, and formulation of finished dosage form products.

Frequently Asked Questions

What is Cambrex Corporation's ticker?

Cambrex Corporation's ticker is CBM

What exchange is Cambrex Corporation traded on?

The company's shares trade on the NYSE stock exchange

Where are Cambrex Corporation's headquarters?

They are based in East Rutherford, New Jersey

How many employees does Cambrex Corporation have?

There are 1001-5000 employees working at Cambrex Corporation

What is Cambrex Corporation's website?

It is http://www.cambrex.com/

What type of sector is Cambrex Corporation?

Cambrex Corporation is in the Healthcare sector

What type of industry is Cambrex Corporation?

Cambrex Corporation is in the Biotechnology industry

Who are Cambrex Corporation's peers and competitors?

The following five companies are Cambrex Corporation's industry peers:

- Anavex Life Sciences

- TG Therapeutics

- Albireo Pharma

- Morphic Holding, Inc.

- Oxford Biomedica